Biochemical characteristics and recent biological knowledge on prostate-specific antigen

Tumori

Volumn 82, Issue 1, 1996, Pages 72-77

  Seregni, Ettore ^a   Botti, Carlo ^a   Ballabio, Giuseppina ^a   Bombardieri, Emilio ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

growth factors; kallikreins; prostate specific antigen

Indexed keywords

GROWTH FACTOR; KALLIKREIN; PROSTATE SPECIFIC ANTIGEN; RETINOIC ACID;

ARTICLE; BREAST CANCER; FEMALE; HUMAN; MALE; MILK; PROSTATE; PROSTATE CANCER;

EID: 0029871275     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169608200116     Document Type: Article

References (70)

1. Abrahamsson P.A., Lilja H.: Free and complexed forms of prostate-specific antigen in serum. Tumour Marker Update, 6: 1-4, 1994.
2. Battifora H.: Immunohistologic applications of antibodies to prostate-specific antigen. In: Tumour Markers in Prostate Cancer, Lange P.H. (Ed.), pp. 3-11, Excerpta Medica, New York, 1986.
3. Bostwick D.G.: Prostatic intraepithelial neoplasia (PIN). Urology, 34 (suppl.): 16-22, 1989.
4. Christensson A., Bjork T, Nilsson O., Dahlen U., Matikainen T., Cockett A.T.K., Abrahamsson P.A., Lilja H.: Serum prostate-specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer. J. Urol., 150: 100-105, 1993.
5. Christensson A., Laurell C.B., Lilja H.: Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine protease inhibitors. Eur. J. Biochem., 194: 755-763, 1990.
6. Christensson A., Lilja H.: Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen. Eur. J. Biochem., 220: 45-53, 1994.
7. Clements J., Mukhtar A.: Glandular kallikreins and prostate-specific antigen are expressed in the human endometrium. J. Clin. Endocrinol. Metab., 78: 1536-1539, 1994.
8. Clemmons D.R.: IGF binding proteins and their functions. Mol. Reprod. Dev., 35: 368-375, 1993.
9. Cohen P., Graves H.C.B., Peehl D.M., Kamarei M., Gruduce L.C., Rosenfeld R.G.: Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J. Clin. Endocrinol. Metab., 75: 1046-1053, 1992.
10. Cohen P., Peehl D.M., Lamson G., Rosenfeld R.: Insulin-like growth factors (IGFs), IGF receptors and IGF-binding proteins in primary cultures of prostate epithelial cells. J. Clin. Endocnnol. Metab., 73: 401-407, 1991.
11. Culig Z., Hobisch A., Cronauer M.V., Radmayr C., Trapman J., Hittmair A., Bartsch G., Klocker H.: Androgen receptor activation in prostatic tumour cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res., 54: 5474-5478, 1994.
12. Elgamal A.A, van De Voorde W., van Poppel H., Lauweryns J., Baert L.: Immunohistochemical localization of prostatespecific markers within the accessory male sex glands of Cowper, Littre and Morgagni. Urology, 44: 84-90, 1994.
13. 2 adenocarcinoma of the prostate. Hum. Pathol., 15: 853-859, 1984.
14. Pong C.J., Sutkowski D.M., Braun E.J., Bauer K.D., Sherwwod E.R., Lee C., Kozlowski J.M.: Effect of retinoic acid on the proliferation and secretory activity of androgen-responsive prostatic carcinoma cells. J. Urol., 149: 1190-1194, 1993.
15. Ford T.F., Butcher D.N., Masters J.R., Parkingson M.C.: Immunocytochemical localization of prostate-specific antigen: specificity and application to clinical practice. Br. J. Urol., 57: 50-55, 1985.
16. Frankel A.R., Rouse R.V., Wang M.C., Chu T.M., Herzenberg L.Á.: Monoclonal antibodies to a human prostate antigen. Cancer Res., 42: 3714-3717, 1982.
17. Gleave M.E., Hsieh J.T., Wu H.C., von Eschenbach A.C., Chung W.K.: Serum prostate-specific antigen levels in mice bearing human prostate LNCaP tumours are determined by tumour volume and endocrine and growth factors. Cancer Res., 52: 1598-1605, 1992.
18. Graves H.C.B., Sensabaugh G.F., Blake R.T.: Postcoital detection of male-specific semen protein: application to the investigation of rape. N. Engl. J. Med., 312: 388-343, 1985.
19. Guo Y., Pili R., Passaniti A.: Regulation of prostate-specific antigen gene expression in LNCaP human prostatic carcinoma cells by growth, dihydrosterone, and extracellular matrix. Prostate, 24: 1-10, 1994.
20. Hakalahti L., Vihko P., Henttu P., Autio-Harmainen H., Soini Y., Vihko R.: Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using Northernblot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies. Int. J. Cancer, 55: 590-597, 1993.
21. Hara M., Inorre T., Fukuyama T.: Some physico-chemical characteristics of gamma-seminoprotein, an antigenic component specific for human seminal piasma. Jap. J. Legal Med., 25: 322-325, 1971.
22. Henttu P., Vihko P.: cDNA coding for the entire human prostate-specific antigen shows homologies to the human tissue kallikrein genes. Biochem. Biophys. Res. Commun., 160: 903-910, 1989.
23. Henttu P., Vihko P.: Growth factor regulation of gene expression in the human prostatic carcinoma cell line LNCaP. Cancer Res., 53: 1051-1058, 1993.
24. Ikonen T., Palvimo J.J., Kallio P.J., Reinikainen P.: Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation. Endocrinology, 135: 1359-1366, 1994.
25. Iwamura M., Sluss P.M., Casameto J.B., Cockett A.T.K.: Insulin-like growth factor I: action and receptor characterization in human prostate cancer cell lines. Prostate, 22: 243-252, 1993.
26. Kanety H., Madjar Y., Dagan Y., Levi J., Papa M.Z., Pariente C., Goldwasser B., Karasik A.: Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is increased in patients with prostate cancer: correlation with serum prostate-specific antigen. J. Clin. Endocrinol. Metab., 77: 229-233, 1993.
27. Katzenellenbogen B.S., Norman M.J.: Multihormonal regulation of the progesterone receptor in MCF-7 human breast cells: interrelationship among insulin/insulin-like growth factor-I, serum and estrogen. Endocrinology, 126: 891-898, 1990.
28. Kavanagh J.P.: Sodium, potassium, calcium, magnesium, zinc, citrate and chloride content of human prostatic and seminal fluid. J. Reprod. Fertil, 75: 35-41, 1985.
29. Killian C.S., Corral D.A., Kawinski E., Constantine R.I.: Mitogenic response of osteoblast cells to prostate- specific antigen suggests an activation of latent TGF-β and a proteolytic modulation of cell adhesion receptors. Biochem. Biophys. Res. Commun., 192; 940-947, 1993.
30. Kuiper G.G., Brinkmann A.O.: Phosphotryptic peptide analysis of the human androgen receptor: detection of a hormone-induced phosphopeptide. Biochemistry, 34: 1851-1857, 1995.
31. Kuriyama M., Wang M.C., Papsidero L.D., Killian C.S., Shimano T., Valenzuela L.A., Nishiura T., Murphy O.P., Chu T.M.: Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay. Cancer Res., 40: 4658-4622, 1980.
32. Li T., Beling C.G.: Isolation and characterization of two specific antigens of human seminal plasma. Fertil. Steril., 24: 134-144, 1973.
33. Lilja H., Abrahamson P.A., Lundwall A.: Semenogelin, the predominant protein in human semen. J. Biol. Chem., 264: 1894-1900, 1989.
34. Lilja H., Laurell C.B.: The predominant protein in human seminal coagulate. Scand. J. Clin. Lab. Invest, 45: 635-641, 1985.
35. Lilja H.: A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J. Clin. Invest., 76: 1899-1903, 1985.
36. Lilja H.: Significance of different molecular forms of serum PSA. Urol. Clin. North Am., 20: 681-685, 1993.
37. Liljia H., Christennsson A., Dahlèn U., Matikainen M.T., Nilsson O.: Prostate-specific antigen in serum occurs predominantly in complex with α-1-antichymotrypsin. Clin. Chem., 37: 1618-1625, 1991.
38. Lundwall A., Lilja H.: Molecular cloning of human prostate - specific antigen cDNA. FEBS Lett., 214: 317-322, 1987.
39. Mast A.E., Enghild J.J., Pizzo S.V., Salvesen G.: Analysis of the plasma elimination kinetics and conformational stabilities of native, proteinase-complexed, and reactive site cleaved serpins: comparison of alpha I-proteinase inhibitor, alpha 1-antichymotrypsin, antithrombin III, alpha 2-antiplasmin, angiotensinogen, and ovalbumin. Biochemistry, 30: 1723-1730, 1991.
40. McGee R.S., Herr J.C.: Human seminal vesicle-specific antigen is a substrate for prostate-specific antigen (or p30). Biol. Reprod., 39: 499-510, 1988.
41. Monne M., Croce C., Yu H., Diamandis E.P.: Molecular characterization of prostate-specific antigen messenger RNA expressed in breast tumors. Cancer Res., 54: 6344-6347, 1994.
42. Mulders T.M.T., Bruning P.F., Bonfrer J.M.G.: Prostate-specific antigen (PSA). A tissue-specific and sensitive tumour marker. Eur, J. Surg. Oncol., 16: 37-41, 1990.
43. Nadji M., Tabei S.Z., Castro A., Chu T.M., Murphy O.P., Wang M.C., Morales A.R.: Prostate-specific antigen: an immunohistologic marker for prostatic neoplasms. Cancer, 48: 1229-1232, 1981.
44. Oesterling J.E., Chan D.W., Epstein J.I., Kimball A.W., Bruzek D.J., Rock R.C., Brendler C.B., Walsh P.C.: Prostate-specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J. Urol., 139: 766-772, 1988.
45. Papsidero L.D., Kuriyama M., Wang M.L., Horoszewicz J.S., Leong S.S., Valenzuela L., Murphy G.P., Chu T.M.: Prostate antigen: a marker for human prostate cells. J. Natl. Cancer Inst., 66: 37-42, 1981.
46. Papsidero L.D., Wang M.C., Valenzuela L.A., Murphy G.P., Chu T.M.: A prostate antigen in sera of prostatic cancer patients. Cancer Res., 40: 2428-2431, 1980.
47. Perlmutter D.H., Glover G.I., Rivetna M., Schasteen C.S., Fallon R.J.: Identification of a serpin-enzyme complex receptor on human hepatoma cells and human monocytes. Proc. Natl. Acad. Sci. USA, 87: 3753-3757, 1990.
48. Qiu S.D., Young C.Y.F., Bilhartz D.L., Prescott J.L., Farrow G.M., He W.W., Tindall D.J.: In situ hybridization of prostate-specific antigen mRNA in human prostate. J. Urol., 144: 1550-1556, 1990.
49. Riegman P.H.J., Klaasen P., van Der Korper J.A.G.M., Romijn J.C., Trapman J.: Molecular cloning and characterization of novel prostate antigen with cDNAs. Biochem. Biophys. Res. Commun., 155: 181-188, 1988.
50. Riegman P.H.J., Vlietstra R.J., van der Korpert J.A.G.M., Romijn J.C., Trapman J.: Characterization of the prostate-specific antigen gene: a novel human kallikrein-like gene. Biochem. Biophys. Res. Commun., 159: 95-102, 1989.
51. Riegman P.H.L., Vliestra R.J., Klaassen P., van der Korput J.A.G.M., Geurts van Kessel A., Romijn J.C., Trapman J.: The prostate-specific antigen gene and the human glandular kallikrein-1 gene are randomly located on chromosome 19. FEBS Lett., 247: 123-126, 1989.
52. Sensabaugh G.F.: Isolation and characterization of a semen-specific protein from human seminal plasma: a potential new marker for semen identification. J. Forens. Sci., 23: 106-115, 1978.
53. Sherwood E., Kozlowski J., Lee C.: Effects of androgens and prostatic stroma on growth and PSA/PAP secretion by the human prostate carcinoma line LNCaP. J. Urol., 143: 203A, 1990.
54. Sinha A.A., Wilson M.J., Gleason D.F.: Immunoelectron microscopic localization of prostatic-specific antigen in human prostate by the protein A-gold complex. Cancer, 60: 1288-1293, 1987.
55. Stamey T.A., Yang N., Hay A.R., McNeal J.E., Freika F.S., Red-wine E.: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N. Engl. J. Med., 317: 909-916, 1987.
56. Stenman U.-H., Leinonen J., Alfthan H., Ranniko S., Tuhkanen K., Alfthan O.: A complex between prostate-specific antigen and α1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res., 51: 222-226, 1991.
57. Sutherland G.R., Baker E., Hyland V.J., Gallen D.F., Close J.A., Treager G.W., Evans B.A., Richards R.I.: Human prostate-specific antigen (PSA) is a member of the glandular kallikrein gene family at 19q13. Cytogenet. Cell. Genet., 48: 205-207, 1988.
58. van Krieken J.H.: Prostate marker immunoreactivity in salivary gland neoplasms. A rare pitfall in immunohistochemistry. Am. J. Surg. Pathol., 17: 410-414, 1993.
59. Wang M.C., Kuriyama M., Loor R., Li S.C., Chu T.M.: Biochemical characterization of human prostate-specific antigen. Fed. Proc., 40: 1564-1569, 1981.
60. Wang M.C., Kuriyama M., Papsidero L.D., Loor R.M., Valenzuela L.A.; Murphy G.P., Chu T.M.: Prostate antigen of human cancer patients. In: Methods in Cancer Research, XIX, Busch H., Yeoman L.C. (Eds.), pp. 179-197, Academic Press, New York, 1982.
61. Wang M.C., Loor R.M., Li S.L., Chu T.M.: Physico-chemical characterization of prostate antigen purified from human prostate gland and seminal plasma. IRSC Med. Sci., Obstet. Gynecol., 11: 327-328, 1983.
62. Wang M.C., Papsidero L.D., Kuriyama M., Valenzuela L.A., Murphy G.P., Chu T.M.: Prostatic antigen: a new potential marker for prostatic cancer. Prostate, 2: 89-96, 1981.
63. Wang M.C.. Valenzuela L.A., Murphy G.P., Chu T.M.: Purification of a human prostate specific antigen. Invest. Urol., 17: 159-163, 1979.
64. Wang M.C., Valenzuela L.A., Murphy G.P., Chu T.M.: Tissue specific and tumour specific antigens in human prostate. Fed. Proc., 36: 1254-1261, 1977.
65. Watt K.W.K., Lee P.J., M'Timkulu T., Chan W.P., Loor R.: Human prostate-specific antigen: structural and functional similarity with serine proteases. Proc. Natl. Acad. Sci. USA, 83: 3166-3170, 1986.
66. Wilding G., Mitchen J., Cheng A.L., Ripple M., Rago R., Mott F., Chang C.: The role of transforming growth factor-β in human prostate cancer. J. Cell. Biochem., 16D: 87-92, 1992.
67. Young C.Y.F., Murtha P.E., Andrews P.E., Lindzey J.K., Tindall D.J.: Antagonism of androgen action in prostate tumour cells by retinoic acid. Prostate, 25: 39-45, 1994.
68. Yu H., Diamandis E.P., Sutherland D.J.: Immunoreactive prostate-specific antigen levels in female and male breast tumours and its association with steroid hormone receptors and patient age. Clin. Biochem., 27: 75-79, 1994.
69. Yu H., Diamandis P.: Prostate-specific antigen in milk of lactating women. Clin. Chem., 41: 54-58, 1995.
70. Yu H., Giai M., Diamandis P.E., Katsaros D., Sutherland D.J.A., Levesque M.A., Roagna R., Ponzone R., Sismondi P.: Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Res., 55: 2104-2110, 1995.